Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1208185

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis


Lucijanic, Marko; Cikara, Tomislav; Bistrovic, Petra; Papic, Ivan; Ortner Hadziabdic, Maja; Busic, Nikolina; Lackovic, Marina; Cesar, Natalia; Koscak, Valentina; Mitrovic, Josko et al.
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis // The Journal of infection, 85 (2022), 2; 174-211 doi:10.1016/j.jinf.2022.04.045 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1208185 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis

Autori
Lucijanic, Marko ; Cikara, Tomislav ; Bistrovic, Petra ; Papic, Ivan ; Ortner Hadziabdic, Maja ; Busic, Nikolina ; Lackovic, Marina ; Cesar, Natalia ; Koscak, Valentina ; Mitrovic, Josko ; Barsic, Bruno ; Lucijanic, Tomo

Izvornik
The Journal of infection (0163-4453) 85 (2022), 2; 174-211

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Remdesivir ; bacteriaemia ; covid-19

Sažetak
Severe and critical COVID-19 patients experience high frequency of bacteremia. Bacteremia might be more frequent in remdesivir treated patients. Gram positive bacteria, especially Enterococcus faecalis are of special concern. Occurrence of bacteremia moderates association of remdesivir use with survival.

Izvorni jezik
Engleski

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Lucijanic, Marko; Cikara, Tomislav; Bistrovic, Petra; Papic, Ivan; Ortner Hadziabdic, Maja; Busic, Nikolina; Lackovic, Marina; Cesar, Natalia; Koscak, Valentina; Mitrovic, Josko et al.
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis // The Journal of infection, 85 (2022), 2; 174-211 doi:10.1016/j.jinf.2022.04.045 (međunarodna recenzija, članak, znanstveni)
Lucijanic, M., Cikara, T., Bistrovic, P., Papic, I., Ortner Hadziabdic, M., Busic, N., Lackovic, M., Cesar, N., Koscak, V. & Mitrovic, J. (2022) Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis. The Journal of infection, 85 (2), 174-211 doi:10.1016/j.jinf.2022.04.045.
@article{article, author = {Lucijanic, Marko and Cikara, Tomislav and Bistrovic, Petra and Papic, Ivan and Ortner Hadziabdic, Maja and Busic, Nikolina and Lackovic, Marina and Cesar, Natalia and Koscak, Valentina and Mitrovic, Josko and Barsic, Bruno and Lucijanic, Tomo}, year = {2022}, pages = {174-211}, DOI = {10.1016/j.jinf.2022.04.045}, keywords = {Remdesivir, bacteriaemia, covid-19}, journal = {The Journal of infection}, doi = {10.1016/j.jinf.2022.04.045}, volume = {85}, number = {2}, issn = {0163-4453}, title = {Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis}, keyword = {Remdesivir, bacteriaemia, covid-19} }
@article{article, author = {Lucijanic, Marko and Cikara, Tomislav and Bistrovic, Petra and Papic, Ivan and Ortner Hadziabdic, Maja and Busic, Nikolina and Lackovic, Marina and Cesar, Natalia and Koscak, Valentina and Mitrovic, Josko and Barsic, Bruno and Lucijanic, Tomo}, year = {2022}, pages = {174-211}, DOI = {10.1016/j.jinf.2022.04.045}, keywords = {Remdesivir, bacteriaemia, covid-19}, journal = {The Journal of infection}, doi = {10.1016/j.jinf.2022.04.045}, volume = {85}, number = {2}, issn = {0163-4453}, title = {Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis}, keyword = {Remdesivir, bacteriaemia, covid-19} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font